Prot# APD356-009: A 104-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients

Project: Research project

Project Details

StatusFinished
Effective start/end date12/4/06 → 1/14/08

Funding

  • ICON Clinical Research, LLC (APD356-009)
  • Arena Pharmaceuticals, Inc. (APD356-009)